Clinical Study of Neflamapimod in Patients With Dementia With Lewy Bodies
Status:
Recruiting
Trial end date:
2025-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether neflamapimod can improve learning skills,
problem solving skills, and memory loss in people diagnosed with DLB. More specifically,
improvement in verbal learning, memory, and attention, as well as cognitive and functional
performance will be measured.
Phase:
Phase 2
Details
Lead Sponsor:
EIP Pharma Inc
Collaborators:
National Institute on Aging (NIA) Worldwide Clinical Trials